(Q44485720)

3 December 2017

Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women (English)

1 reference

chronic renal insufficiency

3 December 2017

1 reference

Kazunobu Ichikawa

1

1 reference

3 December 2017

Tsuneo Konta

2

1 reference

3 December 2017

Mitsuru Emi

3

1 reference

3 December 2017

Sayumi Toriyama

4

1 reference

3 December 2017

Satoshi Takasaki

5

1 reference

3 December 2017

Ami Ikeda

6

1 reference

3 December 2017

Yoko Shibata

7

1 reference

3 December 2017

Noriaki Takabatake

8

1 reference

3 December 2017

Yasuchika Takeishi

9

1 reference

3 December 2017

Takeo Kato

10

1 reference

3 December 2017

Sumio Kawata

11

1 reference

3 December 2017

Isao Kubota

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

8 April 2009

1 reference

3 December 2017

1 reference

3 December 2017

76

1 reference

3 December 2017

2

1 reference

3 December 2017

183-189

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.97

3 December 2017

0 references

cites work

The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Paraoxonase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Paraoxonase 1 polymorphisms and survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Allelic discrimination using fluorogenic probes and the 5' nuclease assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.97

7 January 2021

Identifiers

DOI

10.1038/KI.2009.97

1 reference

3 December 2017

1 reference